Novartis AG
Site-specific chemoenzymatic protein modifications

Last updated:

Abstract:

The present invention relates to methods and reagents for use in site-selective modification of proteins having lysine residues with functionalized peptides using a chemoenzymatic microbial transglutaminase-mediated reaction. The functionalized proteins may be used for study or therapeutic uses.

Status:
Grant
Type:

Utility

Filling date:

29 Nov 2018

Issue date:

13 Apr 2021